Page last updated: 2024-08-24

epigallocatechin gallate and HTLV-I Infections

epigallocatechin gallate has been researched along with HTLV-I Infections in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abu-Elmagd, M; Al-Hejin, A; Alqahtani, MH; Assidi, M; Azar, R; Azhar, E; Barbour, E; Damanhouri, GA; Diab-Assaf, M; Harakeh, S; Kumosani, T; Niedzwiecki, A; Rath, M1

Other Studies

1 other study(ies) available for epigallocatechin gallate and HTLV-I Infections

ArticleYear
pecific nutrient combination effects on tax, NF- κB and MMP-9 in human T-cell lymphotropic virus -1 positive malignant T-lymphocytes.
    BMC cancer, 2015, Volume: 15 Suppl 1

    Topics: Anticarcinogenic Agents; Carcinogenesis; Catechin; CD4-Positive T-Lymphocytes; Cell Line; Cell Nucleus; Cell Proliferation; Gene Expression Regulation, Viral; Gene Products, tax; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Leukemia-Lymphoma, Adult T-Cell; Matrix Metalloproteinase 9; NF-kappa B; Protein Transport; Signal Transduction

2015